Our client had screening assay results for a large antibody panel and protein expression profiles collected from several human tissues. The results were promising, but additional validation was needed.
We obtained publicly available proteomic data presented as IHC stained digital pathology slides of cancer and healthy tissues. Using computer vision, we were able to identify a set of proteins highly expressed in cancer tissues vs. healthy tissues, and translate these into biomarkers for each type of cancer. This analysis provided our client with the additional insight and validation required to continue their drug discovery efforts.
